Human trials under way for new HIV vaccine
January 3rd, 2012 - 5:34 pm ICT by IANSLondon, Jan 3 (IANS) The first human trials for the new HIV injectible vaccine are under way, containing a specific protein which will target the most virulent strain of the virus.
Researchers from the Imperial College London, the Hull York Medical School, the Medical Research Council clinical trial unit and the Infectious Disease Research Institute (IDRI) have come together to evaluate the anti-HIV shot.
The virus’ most virulent strain Clade C has caused the greatest number of HIV infections globally, infecting half of the 34 million people carrying the virus. It is the most prevalent strain in sub-Saharan Africa, according to an Imperial College statement.
Clade C strain is also predominant in India, China and South America. Vaccine candidates relevant to the sub-Saharan epidemic are critically important to prevent large-scale HIV infection in the fight against the global HIV epidemic.
The anti-HIV shot contains trimeric HIV envelope protein (gp140) relevant to Clade C strain. If it does prove to be safe, and brings on immunity, it could be considered for further testing and evaluated for its effectiveness in protecting women against HIV.
The trial has enrolled 36 healthy, HIV-negative women aged 18-45 years at St George’s University of London and the HYMS Experimental Medicine Unit at York Hospital.
“Our collaboration marks an important juncture for the field as we begin to assess which routes of immunisation may provide the best responses to protect women,” said Robin Shattock, professor of immunology at Imperial College, and who leads the consortium which developed the trial.
- Promising target for AIDS vaccine identified - Apr 01, 2011
- Promising new HIV drug keeps virus out of cells - Aug 19, 2010
- Virus that piggybacks on AIDS virus to beat disease developed - Mar 28, 2011
- Washing vagina with soap 'ups risk of HIV infection' - Feb 16, 2011
- 'No mutation of swine flu virus' - Apr 11, 2012
- Why HIV-uninfected babies of mums with HIV are more prone to infections - Feb 09, 2011
- Why TB Matters to Women's Health? - Aug 17, 2010
- 50 pc drop in HIV cases in India in 10 years: UN - Nov 23, 2010
- Indian vaccine to save 250 million lives in Africa - Mar 01, 2011
- Novel discoveries offer new ways to design HIV vaccine - Sep 30, 2010
- New finding may help in dengue fever fight - May 07, 2010
- Pneumonia vaccine offers protection to HIV patients - Mar 04, 2010
- Protein knocks out HIV by starving it of raw materials - Feb 13, 2012
- Tracking evolution of deadly fungus which is one of world's major killers - May 04, 2011
- HIV vaccine being tested in Spain - Sep 29, 2011
Tags: c strain, experimental medicine, hiv envelope protein, hiv epidemic, hiv infection, hiv infections, hiv negative women, hiv vaccine, imperial college london, india china, infectious disease research, injectible, london jan, medical research council, medicine unit, shattock, sub saharan africa, vaccine candidates, virulent strain, virus researchers